The average P/S ratio for GPCR's competitors is 6.28, providing a benchmark for relative valuation. Structure Therapeutics Inc Corp (GPCR) exhibits a P/S ratio of 21.75, which is 246.05% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.